AI-guided structural biology platform that designs tumor-selective oncology therapeutics by integrating anatomical and biochemical context to spare healthy tissue and improve safety and efficacy. Discovery-stage pipeline of antibody–drug conjugates targeting chemoresistant tumor cells and tumor‑subverted immune cells.